Table 2.

Rates and odds ratios for major clinical outcomes in the intent-to-treat population

		Colchicine (n=2235)	Placebo (n=2253)	Odds ratio (95% CI)*	p value
Primary composite endpoint		104 (4·7%)	131 (5·8%)	0·79 (0·61–1·03)	0·081
Components of primary endpoint
	Death	5 (0·2%)	9 (0·4%)	0·56 (0·19–1·67)	..
	Hospitalisation for COVID-19	101 (4·5%)	128 (5·7%)	0·79 (0·60–1·03)	..
Secondary endpoint, mechanical ventilation		11 (0·5%)	21 (0·9%)	0·53 (0·25–1·09)	..

Data are n (%).

^*Odds ratio (95·1% CI) for the primary composite endpoint.